Autism Speaks Archives
Nov. 7, 2019—Vanderbilt researchers are studying how genes affect sleep and circadian disturbances in autism spectrum disorder (ASD) with a goal of creating a genetic risk profile of insomnia in ASD.
Nov. 16, 2017—Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).
Mar. 3, 2016—Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.
Dec. 18, 2014—Stephen Camarata, Ph.D., professor of Hearing and Speech Sciences, has been honored by Autism Speaks, a national autism advocacy and research organization, for dedicated service.
Jan. 23, 2014—Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome.
Jan. 5, 2012—A new Vanderbilt study shows that the over-the-counter supplement melatonin is promising in helping children with autism spectrum disorders (ASD), and their families, sleep better. The study, published in the Journal of Autism and Developmental Disorders, contributes to the growing literature on supplemental melatonin for insomnia in ASD, according to lead author Beth Malow, M.D.,...
Oct. 7, 2011—This Week on VUCast: How sticky mittens could help kids with autism A new toolkit to make doctor’s visits easier May the force be with us… See Yoda’s ties to Vanderbilt It’s all in this week’s VUCast — watch now!